Context Current evidence-based management for clinically localised prostate cancer
includes active surveillance, surgery, external beam radiotherapy (EBRT) and …

To conduct a systematic review of the risks of short‐term outcomes after major treatments for
clinically localised prostate cancer. MEDLINE, EMBASE and the Cochrane Library were …

Purpose To assess long-term quality of life (QoL) impact of treatments in localized prostate
cancer patients treated with radical prostatectomy, external beam radiotherapy or …

Objective To quantify the risk and severity of negative effects of treatment for localised
prostate cancer on long term quality of life. Design Population based, prospective cohort …

Purpose: We evaluated the impact of localized prostate cancer treatment on general, cancer
specific and symptom domains of quality of life for up to 5 years after diagnosis. Materials …

Purpose: Men who undergo primary treatment for prostate cancer can expect changes in
health related quality of life. Long-term changes after treatment are not yet fully understood …

PURPOSE: The current study was undertaken within the framework of a screening trial to
compare the health-related quality-of-life (HRQOL) outcomes of two primary treatment …

Background Few studies have reported on late declines and long-term health-related quality
of life (HRQOL) after prostate cancer (PCa) treatment. Objective We assessed long-term …

BACKGROUND. The primary treatments for clinically localized prostate cancer confer
equivalent cancer control for most patients but disparate side effects. In the current study, the …

Objective To assess treatment related changes in quality of life up to 15 years after
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …